Showing results (51-60 of 408) with videos related to
Sort By:
Pageof 41
Leukemia & Lymphoma|February 1, 2013
Recent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium WorkshopMichael E Williams, Steven H Bernstein, Pedro Jares, et al.American Journal of Hematology|January 7, 2009
Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.Blood Cancer Journal|May 18, 2019
Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphomaGrzegorz S Nowakowski, Tatyana Feldman, Lisa M Rimsza, et al.Blood|November 11, 2010
Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphomaYi Lin, Michael P Gustafson, Peggy A Bulur, et al.Leukemia Research|May 13, 2008
CDDO-imidazolide mediated inhibition of malignant cell growth in Waldenström macroglobulinemiaSherine F Elsawa, Anne J Novak, Deanna Grote, et al.International Journal of Cancer|July 17, 2003
Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphomaJames R Cerhan, Kristin E Anderson, Carol A Janney, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphomaWilliam G Martin, Kay M Ristow, Thomas M Habermann, et al.Leukemia & Lymphoma|January 8, 2024
The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphomaChonlada Laoruangroj, Pamela J Atherton, Gregory A Wiseman, et al.Haematologica|July 22, 2008
Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosisMorie A Gertz, Martha Q Lacy, John A Lust, et al.Case Reports in Hematology|November 14, 2013
Chronic Eosinophilic Leukemia-Not Otherwise Specified (NOS) in the Background of a Large Cell LymphomaWilson I Gonsalves, Rong He, Animesh Pardanani, et al.Pageof 41